SQZ Biotech

SQZ Biotech is a company founded out of the Massachusetts Institute of Technology (MIT). At SQZ they have developed a high-throughput platform - CellSqueeze - for simple and effective material delivery into cells.

Industries

Biotechnology

Headquarters

Watertown, United States

Stage

IPO

Employees

51-200

Links

Org chart

Howard Bernstein

Interim CEO

Collapse

Marshelle Smith Warren

Chief Medical Officer

Richard Capasso

Chief Accounting Officer

Chief People Officer

General Counsel

SVP, CMC & Quality

VP, Translational Medicine

Katherine Seidl

VP, Immunology

Scott Loughhead

VP, Translational Research

Teams

View all

+10

Board of Directors

13 members

Leadership Team

6 members

CEO and Executive Team

5 members

Founding Team

0 members

Discover similar companies

Spero Therapeutics

Cambridge, United States · Post IPO Equity

Atomwise

San Francisco, United States · Grant

Affinivax

Cambridge, United States · Grant

Rigel Pharmaceuticals

South San Francisco, United States · IPO

Evofem Biosciences

San Diego, United States · Post IPO Equity

IsoPlexis

Branford, United States · Series D

Tasso

Seattle, United States · Series B

AVM Biotech

Seattle, United States · Grant

Quanterix

Billerica, United States · IPO

Caladrius Biosciences

Basking Ridge, United States · IPO

Ecovative Design

Green Island, United States · Series D

Summit Therapeutics

Cambridge, United States · Post IPO Equity

The Org
helps you hire
great candidates

It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.